000 01147 a2200325 4500
005 20250513073440.0
264 0 _c19930914
008 199309s 0 0 eng d
022 _a1044-3983
024 7 _a10.1097/00001648-199307000-00016
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJick, S S
245 0 0 _aCombined estrogen and progesterone use and endometrial cancer.
_h[electronic resource]
260 _bEpidemiology (Cambridge, Mass.)
_cJul 1993
300 _a384 p.
_bdigital
500 _aPublication Type: Comparative Study; Letter
650 0 4 _aConfidence Intervals
650 0 4 _aEndometrial Neoplasms
_xepidemiology
650 0 4 _aEstradiol Congeners
_xtherapeutic use
650 0 4 _aEstrogen Replacement Therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLongitudinal Studies
650 0 4 _aMedroxyprogesterone
_xtherapeutic use
650 0 4 _aMiddle Aged
650 0 4 _aRisk Factors
650 0 4 _aWashington
_xepidemiology
773 0 _tEpidemiology (Cambridge, Mass.)
_gvol. 4
_gno. 4
_gp. 384
856 4 0 _uhttps://doi.org/10.1097/00001648-199307000-00016
_zAvailable from publisher's website
999 _c8347027
_d8347027